In Brief: Copley Pharmaceutical
This article was originally published in The Rose Sheet
Copley Pharmaceutical: Launching its generic minoxidil 2% by mid-June, following FDA's May 23 approval of the company's ANDA, Copley says. The product will be sold as "Minoxidil Topical Solution 2% for Men Hair Regrowth Treatment" in a box depicting a balding head. Retail price is expected to be between $12 and $15 per box of two 60 ml bottles, according to the company. Copley's minoxidil approval trails those of Bausch & Lomb, Teva and Alpharm, which began shipping their private label versions of Pharmacia & Upjohn's OTC Rogaine in early May ("The Rose Sheet" May 6, p. 5)...
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review